LECICARBON

This brand name is authorized in Estonia, Poland, United Kingdom

Active ingredients

The drug LECICARBON contains a combination of these active pharmaceutical ingredients (APIs):

1 Sodium dihydrogen phosphate
UNII 3980JIH2SW - SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
Read about Sodium phosphate
2 Sodium hydrogen carbonate
UNII 8MDF5V39QO - SODIUM BICARBONATE

Sodium bicarbonate has antacid properties. Sodium bicarbonate causes neutralisation of gastric acid with the production of carbon dioxide.

Read about Sodium bicarbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A06AX02 Carbon dioxide producing drugs A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AX Other laxatives
Discover more medicines within A06AX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1717130
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 227059, 293733
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100453369

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.